UK markets closed
  • FTSE 100

    +34.98 (+0.47%)
  • FTSE 250

    +93.53 (+0.46%)
  • AIM

    +4.84 (+0.52%)

    +0.0002 (+0.02%)

    -0.0064 (-0.52%)

    -30.60 (-0.15%)
  • CMC Crypto 200

    +3.36 (+0.59%)
  • S&P 500

    +72.88 (+1.73%)
  • DOW

    +424.38 (+1.27%)

    -2.46 (-2.61%)

    +11.70 (+0.65%)
  • NIKKEI 225

    +727.65 (+2.62%)

    +93.19 (+0.46%)
  • DAX

    +101.34 (+0.74%)
  • CAC 40

    +9.19 (+0.14%)

Death by CAPA - Does your CAPA Program need a CAPA? Virtual Webinar, 21st December 2021 -

·3-min read

DUBLIN, December 03, 2021--(BUSINESS WIRE)--The "6-Hour Virtual Seminar - Death by CAPA - Does your CAPA Program need a CAPA?" webinar has been added to's offering.

This 6-hour virtual seminar will help you establish an efficient and effective CAPA (Corrective and Preventive Action) process leading to improved quality and compliance for your company. You'll learn how to streamline and monitor your process to ensure compliance and improved performance. If your CAPA process needs a CAPA, this seminar is for you.

It will discuss regulatory expectations, the myths, and the challenges of managing CAPAs so you can avoid common problems and pitfalls. It will discuss best practices so you can start off on the right foot and always be prepared for an inspection.

This virtual seminar provides detailed lectures on all elements of a CAPA program and how they connect to other parts of your Quality Management System. You will learn how to create a CAPA program that results in improved product quality, reduction in compliance issues, and ultimately leads to improved business success.

Corrective and Preventive Action (CAPA) is the cornerstone of a strong Quality Management System. And yet, many medical device manufacturers struggle to establish and maintain an effective CAPA process. An ineffective CAPA process leads to disastrous consequences like complaints, recalls, 483s, and warning letters. Additionally, an inefficient CAPA system leads to wasted time and resources.

CAPA is so important that it is always emphasized in FDA inspections. It is consistently one of the top reasons for 483 and Warning Letter observations. It is critical that your company establishes a compliant, effective process. This seminar will also provide tools and checklists to ensure your program is inspection ready.

Learning Objectives

  • Understand the regulatory requirements

  • Elements of creating an efficient and effective program

  • CAPA process, tools, and techniques

  • Linkages to your Quality Management System

  • Myths, Challenges, and Best Practices

  • Inspection preparedness

Topics to be covered include:

  • FDA expectations for CAPA

  • Lessons Learned from 483s and warning letters

  • Common problems with CAPA

  • Elements of a CAPA program

  • How to structure your CAPA process

  • How to use IT tools to monitor and maintain your CAPAs

  • Metrics to ensure your CAPAs are timely and effective

  • A toolkit for CAPAs

  • Sources of Data

  • Analysis of Data

  • Failure Investigation

  • Root Cause Analysis

  • CAPA Project Management

  • Problem Solving and Improvement techniques

  • Effectiveness Checks

  • Control, Monitoring, Dissemination of Information

  • Connections within your Quality Management System

    • Non-conforming Product

    • Corrections and Removals

    • Change Control

    • Statistical Techniques

    • Risk Management

  • Bullet-proof Reports

  • Inspection Readiness and Checklist

  • Best Practices

For more information about this webinar visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting